| 0.3 |
1.7 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.1 |
0.7 |
GO:1904844 |
response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 0.1 |
0.1 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) regulation of binding of sperm to zona pellucida(GO:2000359) negative regulation of binding of sperm to zona pellucida(GO:2000360) |
| 0.1 |
0.6 |
GO:1904823 |
pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 0.1 |
0.3 |
GO:0030186 |
melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
| 0.1 |
0.3 |
GO:0018969 |
thiocyanate metabolic process(GO:0018969) |
| 0.1 |
0.4 |
GO:0010982 |
regulation of high-density lipoprotein particle clearance(GO:0010982) positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
| 0.1 |
0.3 |
GO:0070175 |
positive regulation of enamel mineralization(GO:0070175) |
| 0.1 |
0.3 |
GO:1904428 |
negative regulation of tubulin deacetylation(GO:1904428) |
| 0.1 |
0.3 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.1 |
0.6 |
GO:0072658 |
maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.1 |
0.4 |
GO:0035544 |
negative regulation of SNARE complex assembly(GO:0035544) |
| 0.1 |
1.3 |
GO:0010739 |
positive regulation of protein kinase A signaling(GO:0010739) |
| 0.1 |
0.3 |
GO:0006579 |
amino-acid betaine catabolic process(GO:0006579) |
| 0.1 |
0.4 |
GO:0009441 |
glycolate metabolic process(GO:0009441) |
| 0.1 |
0.7 |
GO:0043305 |
negative regulation of mast cell degranulation(GO:0043305) |
| 0.1 |
0.6 |
GO:0060125 |
negative regulation of growth hormone secretion(GO:0060125) |
| 0.1 |
0.5 |
GO:0010387 |
COP9 signalosome assembly(GO:0010387) |
| 0.1 |
0.1 |
GO:0086091 |
regulation of heart rate by cardiac conduction(GO:0086091) |
| 0.1 |
0.2 |
GO:0032242 |
regulation of nucleoside transport(GO:0032242) |
| 0.1 |
1.8 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.1 |
0.8 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.1 |
0.9 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.1 |
0.3 |
GO:0032072 |
plasmacytoid dendritic cell activation(GO:0002270) regulation of restriction endodeoxyribonuclease activity(GO:0032072) negative regulation of apoptotic cell clearance(GO:2000426) |
| 0.1 |
0.2 |
GO:0046521 |
sphingoid catabolic process(GO:0046521) |
| 0.1 |
0.2 |
GO:0000270 |
peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
| 0.1 |
0.5 |
GO:0071104 |
response to interleukin-9(GO:0071104) |
| 0.1 |
0.3 |
GO:1902957 |
negative regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902957) |
| 0.1 |
0.8 |
GO:1902260 |
negative regulation of delayed rectifier potassium channel activity(GO:1902260) |
| 0.1 |
0.2 |
GO:2001037 |
tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
| 0.1 |
0.2 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.1 |
0.2 |
GO:0002384 |
hepatic immune response(GO:0002384) |
| 0.1 |
0.2 |
GO:0042270 |
protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.1 |
4.5 |
GO:0007602 |
phototransduction(GO:0007602) |
| 0.1 |
0.6 |
GO:0009449 |
gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.1 |
0.2 |
GO:0010900 |
negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 0.0 |
0.2 |
GO:0072255 |
metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) positive regulation of phenotypic switching(GO:1900241) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
| 0.0 |
0.3 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) chylomicron remodeling(GO:0034371) |
| 0.0 |
0.3 |
GO:0036518 |
chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.0 |
0.1 |
GO:0021965 |
spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.0 |
0.1 |
GO:0044727 |
DNA demethylation of male pronucleus(GO:0044727) |
| 0.0 |
0.4 |
GO:1905150 |
regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.0 |
0.1 |
GO:0033092 |
positive regulation of immature T cell proliferation in thymus(GO:0033092) |
| 0.0 |
0.1 |
GO:1901291 |
negative regulation of double-strand break repair via single-strand annealing(GO:1901291) |
| 0.0 |
0.2 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 0.0 |
0.2 |
GO:0014806 |
smooth muscle hyperplasia(GO:0014806) |
| 0.0 |
0.2 |
GO:0032971 |
regulation of muscle filament sliding(GO:0032971) |
| 0.0 |
0.4 |
GO:0097475 |
motor neuron migration(GO:0097475) |
| 0.0 |
0.0 |
GO:0071393 |
cellular response to progesterone stimulus(GO:0071393) |
| 0.0 |
0.2 |
GO:0061143 |
alveolar primary septum development(GO:0061143) |
| 0.0 |
0.1 |
GO:0001545 |
primary ovarian follicle growth(GO:0001545) |
| 0.0 |
0.1 |
GO:0003308 |
negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
| 0.0 |
0.8 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.0 |
0.7 |
GO:0071285 |
cellular response to lithium ion(GO:0071285) |
| 0.0 |
0.9 |
GO:0007191 |
adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.0 |
0.3 |
GO:0086053 |
AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.0 |
0.5 |
GO:0032494 |
response to peptidoglycan(GO:0032494) |
| 0.0 |
0.0 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 0.0 |
1.6 |
GO:0006359 |
regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.0 |
0.2 |
GO:0071918 |
urea transmembrane transport(GO:0071918) |
| 0.0 |
0.3 |
GO:1903435 |
positive regulation of constitutive secretory pathway(GO:1903435) |
| 0.0 |
0.2 |
GO:0043091 |
L-arginine import(GO:0043091) arginine import(GO:0090467) |
| 0.0 |
0.2 |
GO:0071874 |
cellular response to norepinephrine stimulus(GO:0071874) |
| 0.0 |
0.3 |
GO:0032621 |
interleukin-18 production(GO:0032621) positive regulation of T-helper 17 cell differentiation(GO:2000321) |
| 0.0 |
0.1 |
GO:0002784 |
antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) |
| 0.0 |
0.0 |
GO:0010644 |
cell communication by electrical coupling(GO:0010644) |
| 0.0 |
0.2 |
GO:0099525 |
presynaptic dense core granule exocytosis(GO:0099525) |
| 0.0 |
0.4 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.0 |
0.3 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.0 |
0.2 |
GO:0021847 |
ventricular zone neuroblast division(GO:0021847) |
| 0.0 |
0.2 |
GO:1902019 |
regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.0 |
0.1 |
GO:0002541 |
activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 0.0 |
0.1 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.0 |
0.1 |
GO:0031635 |
adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
| 0.0 |
0.1 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 0.0 |
0.2 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.0 |
0.1 |
GO:0010248 |
establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.0 |
0.1 |
GO:1901069 |
guanosine-containing compound catabolic process(GO:1901069) |
| 0.0 |
0.2 |
GO:0021993 |
initiation of neural tube closure(GO:0021993) |
| 0.0 |
0.1 |
GO:0052214 |
multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
| 0.0 |
0.1 |
GO:0036451 |
cap mRNA methylation(GO:0036451) |
| 0.0 |
0.1 |
GO:1900104 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.0 |
0.1 |
GO:0072684 |
mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
| 0.0 |
0.1 |
GO:0090598 |
male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.0 |
0.9 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.0 |
0.2 |
GO:0002729 |
positive regulation of natural killer cell cytokine production(GO:0002729) |
| 0.0 |
0.3 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.0 |
0.2 |
GO:0097498 |
endothelial tube lumen extension(GO:0097498) |
| 0.0 |
0.1 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.0 |
0.2 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.0 |
0.2 |
GO:0045229 |
cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.0 |
0.6 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.0 |
0.1 |
GO:0090427 |
regulation of fertilization(GO:0080154) activation of meiosis(GO:0090427) |
| 0.0 |
0.5 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.0 |
0.2 |
GO:1902162 |
mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.0 |
0.1 |
GO:0005986 |
sucrose biosynthetic process(GO:0005986) |
| 0.0 |
0.3 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.0 |
0.1 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.0 |
0.0 |
GO:0035711 |
T-helper 1 cell activation(GO:0035711) |
| 0.0 |
0.1 |
GO:0003331 |
regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
| 0.0 |
0.1 |
GO:0051389 |
inactivation of MAPKK activity(GO:0051389) |
| 0.0 |
0.2 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.0 |
0.7 |
GO:1904778 |
regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.0 |
0.3 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.0 |
0.1 |
GO:0060579 |
ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
| 0.0 |
0.1 |
GO:0015746 |
tricarboxylic acid transport(GO:0006842) succinate transport(GO:0015744) citrate transport(GO:0015746) succinate transmembrane transport(GO:0071422) |
| 0.0 |
0.0 |
GO:0014734 |
skeletal muscle hypertrophy(GO:0014734) |
| 0.0 |
0.1 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.0 |
0.2 |
GO:0003356 |
regulation of cilium beat frequency(GO:0003356) |
| 0.0 |
0.1 |
GO:0030578 |
PML body organization(GO:0030578) |
| 0.0 |
0.1 |
GO:0031247 |
actin rod assembly(GO:0031247) |
| 0.0 |
0.1 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.0 |
1.7 |
GO:0003254 |
regulation of membrane depolarization(GO:0003254) |
| 0.0 |
0.5 |
GO:0006068 |
ethanol catabolic process(GO:0006068) |
| 0.0 |
0.2 |
GO:0042415 |
norepinephrine metabolic process(GO:0042415) |
| 0.0 |
0.1 |
GO:0072369 |
regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.0 |
0.1 |
GO:0010157 |
response to chlorate(GO:0010157) |
| 0.0 |
0.1 |
GO:0034239 |
macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) positive regulation of osteoclast proliferation(GO:0090290) |
| 0.0 |
0.1 |
GO:0000706 |
meiotic DNA double-strand break processing(GO:0000706) double-strand break repair involved in meiotic recombination(GO:1990918) |
| 0.0 |
0.1 |
GO:0040019 |
positive regulation of embryonic development(GO:0040019) |
| 0.0 |
0.1 |
GO:0033591 |
response to L-ascorbic acid(GO:0033591) |
| 0.0 |
0.1 |
GO:0009786 |
regulation of asymmetric cell division(GO:0009786) |
| 0.0 |
0.2 |
GO:0071279 |
cellular response to cobalt ion(GO:0071279) |
| 0.0 |
0.3 |
GO:0001865 |
NK T cell differentiation(GO:0001865) |
| 0.0 |
0.8 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 |
0.1 |
GO:0035407 |
histone H3-T11 phosphorylation(GO:0035407) |
| 0.0 |
0.1 |
GO:0048241 |
epinephrine transport(GO:0048241) |
| 0.0 |
0.1 |
GO:0032203 |
telomere formation via telomerase(GO:0032203) |
| 0.0 |
0.1 |
GO:0034382 |
triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 0.0 |
0.2 |
GO:2000323 |
negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.0 |
0.1 |
GO:0033384 |
geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) |
| 0.0 |
0.3 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.0 |
0.1 |
GO:0070681 |
glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.0 |
0.1 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.0 |
0.1 |
GO:0071418 |
cellular response to amine stimulus(GO:0071418) |
| 0.0 |
0.1 |
GO:0090299 |
regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.0 |
0.1 |
GO:0048075 |
positive regulation of eye pigmentation(GO:0048075) |
| 0.0 |
0.0 |
GO:0031268 |
pseudopodium organization(GO:0031268) |
| 0.0 |
0.2 |
GO:2000544 |
cell chemotaxis to fibroblast growth factor(GO:0035766) endothelial cell chemotaxis to fibroblast growth factor(GO:0035768) regulation of cell chemotaxis to fibroblast growth factor(GO:1904847) regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000544) |
| 0.0 |
0.3 |
GO:0007213 |
G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.0 |
0.2 |
GO:0061088 |
sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.0 |
0.1 |
GO:1904875 |
regulation of DNA ligase activity(GO:1904875) |
| 0.0 |
0.2 |
GO:0006228 |
UTP biosynthetic process(GO:0006228) |
| 0.0 |
0.1 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.0 |
0.1 |
GO:1904481 |
response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
| 0.0 |
0.0 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.0 |
0.3 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 0.0 |
0.2 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.0 |
0.1 |
GO:0032185 |
septin cytoskeleton organization(GO:0032185) |
| 0.0 |
0.1 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.0 |
0.0 |
GO:0018894 |
dibenzo-p-dioxin metabolic process(GO:0018894) |
| 0.0 |
0.2 |
GO:0016560 |
protein import into peroxisome matrix, docking(GO:0016560) |
| 0.0 |
0.1 |
GO:0051083 |
'de novo' cotranslational protein folding(GO:0051083) |
| 0.0 |
0.2 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.0 |
0.2 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.0 |
0.2 |
GO:0033089 |
positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 0.0 |
0.1 |
GO:1902952 |
positive regulation of dendritic spine maintenance(GO:1902952) |
| 0.0 |
0.3 |
GO:2000095 |
regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
| 0.0 |
0.1 |
GO:0003065 |
positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.0 |
0.2 |
GO:0032098 |
regulation of appetite(GO:0032098) |
| 0.0 |
0.2 |
GO:0035020 |
regulation of Rac protein signal transduction(GO:0035020) |
| 0.0 |
0.1 |
GO:0007468 |
regulation of rhodopsin gene expression(GO:0007468) |
| 0.0 |
0.6 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.0 |
0.1 |
GO:0002268 |
follicular dendritic cell differentiation(GO:0002268) |
| 0.0 |
0.2 |
GO:0002457 |
T cell antigen processing and presentation(GO:0002457) |
| 0.0 |
0.0 |
GO:0002522 |
leukocyte migration involved in immune response(GO:0002522) |
| 0.0 |
0.1 |
GO:1902035 |
positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.0 |
0.1 |
GO:0046985 |
positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.0 |
0.1 |
GO:0046618 |
drug export(GO:0046618) |
| 0.0 |
0.1 |
GO:0021861 |
forebrain radial glial cell differentiation(GO:0021861) |
| 0.0 |
0.2 |
GO:0015812 |
gamma-aminobutyric acid transport(GO:0015812) |
| 0.0 |
0.2 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.0 |
0.1 |
GO:0072334 |
UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
| 0.0 |
0.0 |
GO:0046984 |
regulation of hemoglobin biosynthetic process(GO:0046984) |
| 0.0 |
0.4 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.0 |
0.0 |
GO:0009236 |
cobalamin biosynthetic process(GO:0009236) |
| 0.0 |
0.1 |
GO:0014022 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.0 |
0.1 |
GO:0061324 |
glial cell fate determination(GO:0007403) canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation(GO:0061324) regulation of chromatin-mediated maintenance of transcription(GO:1904499) positive regulation of chromatin-mediated maintenance of transcription(GO:1904501) regulation of euchromatin binding(GO:1904793) |
| 0.0 |
0.1 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.0 |
0.2 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.0 |
0.2 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.0 |
0.6 |
GO:0002026 |
regulation of the force of heart contraction(GO:0002026) |
| 0.0 |
0.1 |
GO:0071883 |
activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.0 |
0.1 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 0.0 |
0.1 |
GO:0031284 |
positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.0 |
0.2 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.0 |
0.2 |
GO:0006782 |
protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.0 |
0.1 |
GO:0044240 |
multicellular organism lipid catabolic process(GO:0044240) |
| 0.0 |
0.1 |
GO:0006196 |
AMP catabolic process(GO:0006196) |
| 0.0 |
0.1 |
GO:1901526 |
positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 0.0 |
0.1 |
GO:0010908 |
regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.0 |
0.1 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.0 |
0.1 |
GO:0032224 |
positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 0.0 |
0.1 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.0 |
0.3 |
GO:0031643 |
positive regulation of myelination(GO:0031643) |
| 0.0 |
0.0 |
GO:0086045 |
membrane depolarization during AV node cell action potential(GO:0086045) membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
| 0.0 |
0.1 |
GO:1990167 |
protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
| 0.0 |
0.0 |
GO:0002034 |
renin-angiotensin regulation of aldosterone production(GO:0002018) regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 0.0 |
0.1 |
GO:0070294 |
renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.0 |
0.0 |
GO:0006174 |
dADP phosphorylation(GO:0006174) dGDP phosphorylation(GO:0006186) AMP phosphorylation(GO:0006756) CDP phosphorylation(GO:0061508) dAMP phosphorylation(GO:0061565) CMP phosphorylation(GO:0061566) dCMP phosphorylation(GO:0061567) GDP phosphorylation(GO:0061568) UDP phosphorylation(GO:0061569) dCDP phosphorylation(GO:0061570) TDP phosphorylation(GO:0061571) |
| 0.0 |
0.1 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.0 |
0.0 |
GO:0040040 |
thermosensory behavior(GO:0040040) |
| 0.0 |
0.3 |
GO:0009952 |
anterior/posterior pattern specification(GO:0009952) |
| 0.0 |
0.0 |
GO:0097045 |
activation of blood coagulation via clotting cascade(GO:0002543) phosphatidylserine exposure on blood platelet(GO:0097045) positive regulation of potassium ion export(GO:1902304) |
| 0.0 |
0.0 |
GO:0006726 |
eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.0 |
0.1 |
GO:1901098 |
positive regulation of autophagosome maturation(GO:1901098) |
| 0.0 |
0.1 |
GO:0003025 |
regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 0.0 |
0.1 |
GO:0061767 |
negative regulation of lung blood pressure(GO:0061767) |
| 0.0 |
0.0 |
GO:0003149 |
membranous septum morphogenesis(GO:0003149) |
| 0.0 |
0.1 |
GO:0019264 |
glycine biosynthetic process from serine(GO:0019264) |
| 0.0 |
0.1 |
GO:0043249 |
erythrocyte maturation(GO:0043249) |
| 0.0 |
0.1 |
GO:0048749 |
compound eye development(GO:0048749) |
| 0.0 |
0.0 |
GO:0042245 |
RNA repair(GO:0042245) |
| 0.0 |
0.1 |
GO:0060523 |
prostate epithelial cord elongation(GO:0060523) |
| 0.0 |
0.2 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.0 |
2.4 |
GO:0007601 |
visual perception(GO:0007601) |
| 0.0 |
0.5 |
GO:0061718 |
NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.0 |
0.1 |
GO:0014809 |
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.0 |
0.1 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.0 |
0.0 |
GO:0009794 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.0 |
0.2 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.0 |
0.2 |
GO:0006006 |
glucose metabolic process(GO:0006006) |
| 0.0 |
0.1 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.0 |
0.1 |
GO:0045007 |
depurination(GO:0045007) |
| 0.0 |
0.1 |
GO:1902741 |
interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
| 0.0 |
0.1 |
GO:2000825 |
positive regulation of androgen receptor activity(GO:2000825) |
| 0.0 |
0.1 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.0 |
0.0 |
GO:0003032 |
detection of oxygen(GO:0003032) |
| 0.0 |
0.0 |
GO:2000382 |
positive regulation of mesoderm development(GO:2000382) |
| 0.0 |
0.1 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.0 |
0.2 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.0 |
0.0 |
GO:0046035 |
CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.0 |
0.0 |
GO:0097010 |
eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
